AI Science Tracker

Generative design of de novo AAV vectors with unique serological profiles

University of Toronto · 9 Nov 2026 · biology

Discovery

Generative design of de novo AAV vectors with unique serological profiles

The preprint abstract reports a variational autoencoder trained on natural AAV sequences to generate capsids. More than 255 designs were synthesized and tested in vitro. Seven transduced human cells at over 50% efficiency; four of those avoided neutralization by every AAV-reactive human serum sample tested, at the reported NT50 threshold below 1:50. This establishes in-vitro capsid properties, not in-vivo delivery or clinical efficacy. Review is limited to the abstract and original-server metadata.

Technology: Variational autoencoder (generative model of AAV capsid sequences)

Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Preprint
  • Test type: direct test
  • Tested: More than 255 AI-generated capsid designs were synthesized and tested in vitro; seven transduced human cells above 50% efficiency and four avoided neutralizing antibodies in all reactive human sera.
  • Still unknown: Review limited to the indexed abstract and publication metadata; full-paper methods and additional limitations were not assessed.
  • AI role: A variational autoencoder learned AAV sequence constraints from natural sequences and generated functional capsid proteins de novo, with a second design campaign exploring uncertain regions.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A%2210.64898%2F2026.11.06.764881%22&resultType=core&format=json · https://api.biorxiv.org/details/biorxiv/10.64898/2026.11.06.764881

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.